Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Related Articles by Review for PubMed (Select 9184625)

1.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

PMID:
9184625
2.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
3.

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Figgitt DP, McClellan KJ.

Drugs. 2000 Oct;60(4):925-54. Review.

PMID:
11085201
4.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
5.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

PMID:
9393392
6.

Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.

Denys D.

Psychiatr Clin North Am. 2006 Jun;29(2):553-84, xi. Review.

PMID:
16650723
7.

Pharmacotherapy of obsessive compulsive disorder.

Goodman WK, McDougle CJ, Price LH.

J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. Review.

PMID:
1532962
8.

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.

Dell'Osso B, Allen A, Hollander E.

Expert Opin Pharmacother. 2005 Dec;6(15):2727-40. Review.

PMID:
16316311
9.

Pharmacologic therapy of obsessive compulsive disorder.

DeVeaugh-Geiss J.

Adv Pharmacol. 1994;30:35-52. Review.

PMID:
7833296
10.

Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.

Owen RT.

Drugs Today (Barc). 2008 Dec;44(12):887-93. doi: 10.1358/dot.2008.44.12.1299291. Review.

PMID:
19198698
11.

On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?

Todorov C, Freeston MH, Borgeat F.

Can J Psychiatry. 2000 Apr;45(3):257-62. Review.

PMID:
10779882
12.

OCD: where the serotonin selectivity story begins.

Pigott TA.

J Clin Psychiatry. 1996;57 Suppl 6:11-20. Review.

PMID:
8647793
13.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928
14.

Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

Paediatr Drugs. 2001;3(10):763-81. Review. Erratum in: Paediatr Drugs 2001;3(11):801.

PMID:
11706925
15.

Pharmacotherapy of primary obsessive-compulsive disorder: review of the literature.

Ellingrod VL.

Pharmacotherapy. 1998 Sep-Oct;18(5):936-60. Review.

PMID:
9758307
16.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
17.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
18.

Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.

McDougle CJ, Goodman WK, Price LH.

J Clin Psychiatry. 1994 Mar;55 Suppl:24-31. Review.

PMID:
7521326
19.

Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.

Dominguez RA.

J Clin Psychiatry. 1992 Oct;53 Suppl:56-9. Review.

PMID:
1429485
20.

[Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].

Flament MF.

Encephale. 1993 Mar-Apr;19(2):75-81. Review. French.

PMID:
8275900
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk